{"component": "definition", "props": {"groups": [{"samples": [{"hash": "eldirg4depU", "uri": "https://aablawards.com/Docs/Nomination%20form%20-%20COMPANY%20OF%20THE%20YEAR%20GLOBAL.pdf", "label": "aablawards.com", "score": 17.0382709503, "published": false}, {"hash": "c0Zf7biy7lu", "uri": "https://aablawards.com/wp-content/uploads/2023/03/Nomination-form-Philanthropist-of-the-Year.pdf", "label": "aablawards.com", "score": 11.6160163879, "published": false}, {"hash": "WY7kq7XtJO", "uri": "https://aablawards.com/wp-content/uploads/2023/03/Nomination-form-Innovator-of-the-Year.pdf", "label": "aablawards.com", "score": 11.6160163879, "published": false}], "size": 10, "snippet_links": [{"key": "the-information", "type": "clause", "offset": [6, 21]}, {"key": "research-panel", "type": "definition", "offset": [54, 68]}, {"key": "clause-3", "type": "definition", "offset": [92, 100]}], "snippet": "means the information researched and developed by the Research Panel, more fully defined in Clause 3 (f) (ii) below.", "hash": "f5233b14a3989693aa53874b1ea2a152", "id": 1}, {"samples": [{"hash": "lG6IvdjGX9J", "uri": "/contracts/lG6IvdjGX9J#research-information", "label": "Non Exclusive License Agreement (Alexion Pharmaceuticals Inc)", "score": 18.0, "published": true}, {"hash": "5UfeDOtQKgy", "uri": "/contracts/5UfeDOtQKgy#research-information", "label": "Non Exclusive License Agreement (Alexion Pharmaceuticals Inc)", "score": 18.0, "published": true}], "size": 2, "snippet_links": [{"key": "specific-items", "type": "clause", "offset": [15, 29]}, {"key": "relating-to", "type": "definition", "offset": [67, 78]}, {"key": "sca-discoveries", "type": "definition", "offset": [79, 94]}, {"key": "owned-by", "type": "definition", "offset": [104, 112]}, {"key": "on-the-effective-date", "type": "clause", "offset": [181, 202]}, {"key": "appendix-ii", "type": "definition", "offset": [240, 251]}], "snippet": "means only the specific items of technical know-how or information relating to SCA DISCOVERIES that are owned by ENZON or its AFFILIATES or in ENZON's or its AFFILIATES' possession on the EFFECTIVE DATE and are expressly listed in attached Appendix II.", "hash": "4e95b58229894ee3b55c2d26b51a16e6", "id": 2}, {"samples": [{"hash": "6j3mDOJlA1p", "uri": "/contracts/6j3mDOJlA1p#research-information", "label": "Option Agreement (Vysis Inc)", "score": 18.0, "published": true}, {"hash": "1tFPdOPB1JA", "uri": "/contracts/1tFPdOPB1JA#research-information", "label": "Exclusive License Agreement (Vysis Inc)", "score": 18.0, "published": true}], "size": 2, "snippet_links": [{"key": "technical-data", "type": "definition", "offset": [6, 20]}, {"key": "biological-materials", "type": "definition", "offset": [82, 102]}, {"key": "resulting-from-the", "type": "clause", "offset": [223, 241]}, {"key": "performance-of-research", "type": "clause", "offset": [242, 265]}, {"key": "research-agreement", "type": "definition", "offset": [276, 294]}, {"key": "subject-matter", "type": "clause", "offset": [352, 366]}, {"key": "by-licensee", "type": "clause", "offset": [378, 389]}, {"key": "in-the-event", "type": "clause", "offset": [391, 403]}, {"key": "computer-software", "type": "definition", "offset": [409, 426]}, {"key": "management-systems", "type": "definition", "offset": [442, 460]}, {"key": "in-the-performance", "type": "clause", "offset": [486, 504]}, {"key": "transfer-of-the", "type": "clause", "offset": [663, 678]}, {"key": "possession-of-equipment", "type": "clause", "offset": [688, 711]}], "snippet": "means technical data, processes, methods, inventions, compositions-of-matter, and biological materials, equipment, instruments, apparatuses, devices, articles of manufacture or component parts(s) thereof developed under or resulting from the performance of Research under the Research Agreement and improvements thereof, except for improvements on new subject matter not funded by Licensee. In the event that computer software or information management systems are created or developed in the performance of Research under the Research Agreement such computer software or information management systems shall be treated as Research Information. There shall be no transfer of the physical possession of equipment, instruments, apparatuses, devices, articles of manufacture or component part(s) thereof (except biological materials) comprising Research Information.", "hash": "b1ceb59981a35ffe20005a1b13e88f99", "id": 3}, {"samples": [{"hash": "gmLh0IVVAxg", "uri": "/contracts/gmLh0IVVAxg#research-information", "label": "License Agreement (Oncormed Inc)", "score": 18.0, "published": true}, {"hash": "7Rsdlycp5Yu", "uri": "/contracts/7Rsdlycp5Yu#research-information", "label": "License Agreement (Oncormed Inc)", "score": 18.0, "published": true}], "size": 2, "snippet_links": [{"key": "collaborative-services", "type": "clause", "offset": [94, 116]}, {"key": "pursuant-to-this-agreement", "type": "clause", "offset": [117, 143]}], "snippet": "means all data, know-how, information, conclusions and reports produced by OncorMed under the Collaborative Services pursuant to this Agreement.", "hash": "0c10a07ece704a6da3e72ac68063977d", "id": 4}, {"samples": [{"hash": "lOCxlaPJeoq", "uri": "/contracts/lOCxlaPJeoq#research-information", "label": "Research and License Agreement (Nymox Pharmaceutical Corp)", "score": 18.0, "published": true}, {"hash": "6981ypPtNNZ", "uri": "/contracts/6981ypPtNNZ#research-information", "label": "Research and License Agreement (Nymox Pharmaceutical Corp)", "score": 18.0, "published": true}], "size": 2, "snippet_links": [{"key": "research-data", "type": "definition", "offset": [10, 23]}, {"key": "process-information", "type": "clause", "offset": [35, 54]}, {"key": "other-information", "type": "definition", "offset": [58, 75]}, {"key": "pertaining-to", "type": "definition", "offset": [76, 89]}, {"key": "sponsored-research", "type": "definition", "offset": [94, 112]}, {"key": "principal-investigators", "type": "clause", "offset": [126, 149]}, {"key": "on-the-effective-date", "type": "clause", "offset": [150, 171]}, {"key": "obligation-to", "type": "clause", "offset": [220, 233]}, {"key": "third-party", "type": "definition", "offset": [238, 249]}, {"key": "maintain-in-confidence", "type": "clause", "offset": [253, 275]}, {"key": "in-the-performance", "type": "clause", "offset": [323, 341]}], "snippet": "means any research data, formulas, process information or other information pertaining to the SPONSORED RESEARCH (a) known to PRINCIPAL INVESTIGATORS on the EFFECTIVE DATE and which PRINCIPAL INVESTIGATORS are not under obligation to any third party to maintain in confidence, or (b) thereafter produced by an INVESTIGATOR in the performance of SPONSORED RESEARCH.", "hash": "17513b1373d60c28dca2335192c99c58", "id": 5}, {"samples": [{"hash": "aF4xmVHgULG", "uri": "/contracts/aF4xmVHgULG#research-information", "label": "Research Agreement (Senesco Technologies Inc)", "score": 18.0, "published": true}, {"hash": "25fZhqyP8si", "uri": "https://investors.eloxxpharma.com/static-files/94f2e6c7-ab9b-4dc4-868a-61a3083d8abc", "label": "investors.eloxxpharma.com", "score": 9.965092659, "published": false}], "size": 2, "snippet_links": [{"key": "all-information", "type": "clause", "offset": [6, 21]}, {"key": "chemical-compound", "type": "definition", "offset": [62, 79]}, {"key": "biological-material", "type": "definition", "offset": [155, 174]}, {"key": "in-the-course-of", "type": "definition", "offset": [201, 217]}, {"key": "research-plan", "type": "clause", "offset": [237, 250]}], "snippet": "means all information, know-how, and materials (including any chemical compound or substances, biological cell, or component thereof, whether derived from biological material or synthesized) developed in the course of research under the Research Plan, but which does not constitute an Invention.", "hash": "5033f3b0092a21292ea2fd4c96e35f52", "id": 6}, {"samples": [{"hash": "kRy6dHB45np", "uri": "/contracts/kRy6dHB45np#research-information", "label": "Agreement for the Construction and Operation of a Therapeutic Antibody Centre (Leukosite Inc)", "score": 18.0, "published": true}, {"hash": "jB5BYLW5rly", "uri": "/contracts/jB5BYLW5rly#research-information", "label": "Agreement for the Construction and Operation of a Therapeutic Antibody Centre (Leukosite Inc)", "score": 18.0, "published": true}], "size": 2, "snippet_links": [{"key": "process-information", "type": "clause", "offset": [22, 41]}, {"key": "other-information", "type": "definition", "offset": [45, 62]}, {"key": "in-the-course-of", "type": "definition", "offset": [73, 89]}, {"key": "the-research", "type": "clause", "offset": [90, 102]}], "snippet": "means data, formulae, process information or other information developed in the course of the Research;", "hash": "a902ada442e2e888bfa50f2863d9a776", "id": 7}, {"samples": [{"hash": "fe5l3cLqzRk", "uri": "/contracts/fe5l3cLqzRk#research-information", "label": "Exclusive License and Research Collaboration Agreement (Artiva Biotherapeutics, Inc.)", "score": 32.266254425, "published": true}, {"hash": "cpF43G0krX4", "uri": "/contracts/cpF43G0krX4#research-information", "label": "Exclusive License and Research Collaboration Agreement (Artiva Biotherapeutics, Inc.)", "score": 32.1649551392, "published": true}], "size": 2, "snippet_links": [{"key": "how-and-trade-secrets", "type": "clause", "offset": [92, 113]}, {"key": "to-practice", "type": "clause", "offset": [144, 155]}, {"key": "in-the-course-of", "type": "definition", "offset": [156, 172]}, {"key": "the-research-program", "type": "clause", "offset": [193, 213]}], "snippet": "means, on a Research Program-by-Research Program basis, all protocols, formulas, data, know-how and trade secrets that are conceived or reduced to practice in the course of, or as a result of, the Research Program [***].", "hash": "a2d2315221106ddf35a515696ccfd66f", "id": 8}, {"samples": [{"hash": "ifTgzkejliL", "uri": "/contracts/ifTgzkejliL#research-information", "label": "Sponsored Research Agreement (ROKIT America, Inc.)", "score": 37.2491455078, "published": true}, {"hash": "kQKPa2syVnD", "uri": "/contracts/kQKPa2syVnD#research-information", "label": "Sponsored Research Agreement (CureVac B.V.)", "score": 31.5598907471, "published": true}], "size": 2, "snippet_links": [{"key": "research-results", "type": "clause", "offset": [10, 26]}, {"key": "in-the-performance", "type": "clause", "offset": [57, 75]}, {"key": "sponsored-research", "type": "definition", "offset": [83, 101]}], "snippet": "means any research results produced by the Investigators in the performance of the Sponsored Research.", "hash": "e048f65fe46986224a12d0a5bf3d2f01", "id": 9}, {"samples": [{"hash": "7YhXRobQWtX", "uri": "https://www.bclaws.gov.bc.ca/civix/document/id/oic/oic_cur/0160_2021", "label": "www.bclaws.gov.bc.ca", "score": 8.553730011, "published": false}, {"hash": "3S5asMEj2ys", "uri": "https://www.bclaws.gov.bc.ca/civix/document/id/oic/arc_oic/0160_2021", "label": "www.bclaws.gov.bc.ca", "score": 8.553730011, "published": false}], "size": 2, "snippet_links": [{"key": "data-and-data", "type": "clause", "offset": [16, 29]}, {"key": "appendix-a", "type": "clause", "offset": [50, 60]}, {"key": "permitted-parties", "type": "definition", "offset": [125, 142]}, {"key": "for-the-purposes", "type": "clause", "offset": [143, 159]}], "snippet": "means the Micro Data and Data Cubes identified in Appendix A to this schedule and collected, used and disclosed by or to the Permitted Parties for the purposes referred to in Section 2.0 of this schedule.", "hash": "d06bab754fd0948ae9e414fce30421cf", "id": 10}], "next_curs": "CmESW2oVc35sYXdpbnNpZGVyY29udHJhY3Rzcj0LEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIdcmVzZWFyY2gtaW5mb3JtYXRpb24jMDAwMDAwMGEMogECZW4YACAA", "definition": {"title": "Research Information", "size": 46, "snippet": "means the information researched and developed by the Research Panel, more fully defined in Clause 3 (f) (ii) below.", "id": "research-information", "examples": ["GlobeImmune may, at its election and expense, pursue and obtain patent protection for any inventions that may incorporate use of the Material or the <strong>Research Information</strong>.", "Within ten (10) days after the expiration or termination of this Agreement, Recipient shall return all Material and any copies of the Confidential Information and <strong>Research Information</strong> in Recipient\u2019s possession or within its control to GlobeImmune or shall deliver written notice certifying that all Material, Confidential Information and <strong>Research Information</strong> has been destroyed.", "The words \u201cReproduced by permission of <strong>Research Information</strong> Ltd\u201d must appear on such material in such a position and typeface as to be clearly visible to the user.", "Site will keep all <strong>Research Information</strong> that contains personal identification information (e.g., contact information, Social Security Numbers), if any, confidential and secure by storing it in a locked cabinet or file until it is sent to MDRC.", "<strong>Research Information</strong> that bears the civil service designation \u2018top secret\u2019, \u2018secret\u2019 or \u2018confidential\u2019, or that must be treated confidentially on the basis of legislation.", "At that time, the Company shall have a fully-paid-up, irrevocable license to the Licensed Patent, Licensed <strong>Research Information</strong>, and Licensed Materials.", "The Regents expressly reserves the right to transfer replicable Background Biological Materials and replicable biological materials comprising <strong>Research Information</strong> as provided in this Paragraph 15.1 to Universities and nonprofit research organizations to the extent that such transfer does not compete with Licensee.", "Upon the effectiveness of a Participation Waiver as set forth in Sections 3.3 or 3.4(b), the Non-Participating Party shall grant to the Participating Party an exclusive, worldwide license, with rights to sub-license, under the Non-Participating Party&#x27;s interests in the <strong>Research Information</strong> and Joint Patents, to make, use, and sell the particular Collaboration Product or Other Product subject to such Participation Waiver.", "<strong>Research Information</strong> that includes the name or any other designation of the person or organisation to which it relates or by which it was provided.", "If MDRC has any reason to believe that there has been a breach of confidentiality of <strong>Research Information</strong>, whether through deliberate or inadvertent disclosure, MDRC will notify Site within 24 hours of the discovery of breach or possible breach."], "related": [["program-information", "Program Information", "Program Information"], ["product-information", "Product Information", "Product Information"], ["confidential-system-information", "Confidential System Information", "Confidential System Information"], ["licensed-information", "Licensed Information", "Licensed Information"], ["research-data", "Research Data", "Research Data"]], "related_snippets": [], "updated": "2026-04-18T05:49:41+00:00"}, "json": true, "cursor": ""}}